These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 2738181

  • 1. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D, Silver JM, Opler LA.
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [Abstract] [Full Text] [Related]

  • 2. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP, Herbstein J, Damlouji N.
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [Abstract] [Full Text] [Related]

  • 3. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
    Ponto LB, Perry PJ, Liskow BI, Seaba HH.
    Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909
    [Abstract] [Full Text] [Related]

  • 4. [Adverse drug reactions in combined treatment with tricyclic antidepressants and monoamine oxidase inhibitors].
    von Oefele K, Grohmann R, Hippius H, Rüther E.
    Nervenarzt; 1988 Feb; 59(2):118-23. PubMed ID: 3362260
    [No Abstract] [Full Text] [Related]

  • 5. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH.
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [Abstract] [Full Text] [Related]

  • 6. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM, de Leon J.
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [Abstract] [Full Text] [Related]

  • 7. On combining TCAs and MAOIs.
    Grounds D.
    Aust N Z J Psychiatry; 1993 Jun; 27(2):344, 346. PubMed ID: 8363548
    [No Abstract] [Full Text] [Related]

  • 8. MAOIs in the contemporary treatment of depression.
    Thase ME, Trivedi MH, Rush AJ.
    Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
    [Abstract] [Full Text] [Related]

  • 9. Tricyclic antidepressant-induced seizures and plasma drug concentration.
    Preskorn SH, Fast GA.
    J Clin Psychiatry; 1992 May; 53(5):160-2. PubMed ID: 1592842
    [Abstract] [Full Text] [Related]

  • 10. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH, Baxter LR, Rego J.
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [Abstract] [Full Text] [Related]

  • 11. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J, Quitkin F, Harrison W, Tricamo E, McGrath P.
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [Abstract] [Full Text] [Related]

  • 12. Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
    Beasley CM, Masica DN, Heiligenstein JH, Wheadon DE, Zerbe RL.
    J Clin Psychopharmacol; 1993 Oct; 13(5):312-20. PubMed ID: 8227489
    [Abstract] [Full Text] [Related]

  • 13. 'Spontaneous' hypertensive episodes with monoamine oxidase inhibitors.
    Fallon B, Foote B, Walsh BT, Roose SP.
    J Clin Psychiatry; 1988 Apr; 49(4):163-5. PubMed ID: 3281932
    [Abstract] [Full Text] [Related]

  • 14. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI, Fischer HD, Herrmann N, Huo CY, Anderson GM, Rochon PA.
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [Abstract] [Full Text] [Related]

  • 15. Managing rapid metabolizers of antidepressants.
    Kraus RP, Diaz P, McEachran A.
    Depress Anxiety; 2009 Dec; 4(6):320-7. PubMed ID: 9166660
    [Abstract] [Full Text] [Related]

  • 16. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.
    Woolf AD, Erdman AR, Nelson LS, Caravati EM, Cobaugh DJ, Booze LL, Wax PM, Manoguerra AS, Scharman EJ, Olson KR, Chyka PA, Christianson G, Troutman WG.
    Clin Toxicol (Phila); 2007 Dec; 45(3):203-33. PubMed ID: 17453872
    [Abstract] [Full Text] [Related]

  • 17. Adverse consequences of fluoxetine-MAOI combination therapy.
    Feighner JP, Boyer WF, Tyler DL, Neborsky RJ.
    J Clin Psychiatry; 1990 Jun; 51(6):222-5. PubMed ID: 2347858
    [Abstract] [Full Text] [Related]

  • 18. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [Abstract] [Full Text] [Related]

  • 19. Monoamine oxidase-inhibiting antidepressants. A clinical update.
    Murphy DL, Sunderland T, Cohen RM.
    Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
    [Abstract] [Full Text] [Related]

  • 20. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G, Saxena BM, Nair NP, Kutcher SP, Bakish D, Bradwejn J, Kennedy SH, Sharma V, Remick RA, Kukha-Mohamad SA.
    Clin Neuropharmacol; 1993 Sep; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.